Answers are grounded in this paper and cite their sources.
Systematic review evaluates therapeutic responses to JAK inhibitors in chronic actinic dermatitis, highlighting potential efficacy for refractory disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Vahabi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: